Showing results (271-280 of 282) with videos related to
Sort By:
Pageof 29
Gut|October 27, 2021
Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort studyAntonio Tursi, Giovanni Brandimarte, Francesco Di Mario, et al.Inflammatory Bowel Diseases|April 2, 2022
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational StudyGaetano Bergamaschi, Fabiana Castiglione, Renata D'Incà, et al.Gut|September 13, 2017
ROC-king onwards: intraepithelial lymphocyte counts, distribution & role in coeliac disease mucosal interpretationKamran Rostami, Michael N Marsh, Matt W Johnson, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|January 14, 2020
International Consensus on Diverticulosis and Diverticular Disease. Statements from the 3rd International Symposium on Diverticular DiseaseAntonio Tursi, Giovanni Brandimarte, Francesco Di Mario, et al.Intestinal Research|August 12, 2024
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international studyAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.The American Journal of Gastroenterology|June 14, 2023
Prevalence and Natural History of Segmental Colitis Associated With DiverticulosisAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.United European Gastroenterology Journal|August 8, 2023
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysisAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.Exploration of Neuroscience|August 26, 2025
Most prominent challenges in translational neuroscience and strategic solutions to bridge the gaps: Perspectives from an editorial board interrogationDirk M Hermann, Marco Bacigaluppi, Claudio L Bassetti, et al.Inflammatory Bowel Diseases|May 17, 2022
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational StudyAntonio Tursi, Giammarco Mocci, Leonardo Allegretta, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|December 19, 2022
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in ItalyAntonio Tursi, Giammarco Mocci, Antonio Cuomo, et al.Pageof 29